Editorial: Allogenic hematopoietic cell transplant in hematological malignancies: controversies and perspective.
作者信息
Leotta Salvatore, Giammarco Sabrina, Mariotti Jacopo
机构信息
Azienda Ospedaliero-Universitaria Policlinico "G-Rodolico"- San Marco - Catania, Catania, Italy.
Dipartimento di Scienze di Laboratorio e Infettivologiche, Agostino Gemelli University Policlinic Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
出版信息
Front Oncol. 2025 Mar 19;15:1582751. doi: 10.3389/fonc.2025.1582751. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Allogenic hematopoietic cell transplant in hematological malignancies: controversies and perspective.社论：血液系统恶性肿瘤中的异基因造血细胞移植：争议与展望
Front Oncol. 2025 Mar 19;15:1582751. doi: 10.3389/fonc.2025.1582751. eCollection 2025.
2
[Second allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and donor changes in relapsed hematological malignancies after the first allogeneic transplant].[首次异基因造血干细胞移植后复发血液系统恶性肿瘤的二次异基因造血干细胞移植：采用减低剂量预处理及供者变更]
Zhonghua Xue Ye Xue Za Zhi. 2023 Jun 14;44(6):465-471. doi: 10.3760/cma.j.issn.0253-2727.2023.06.004.
3
Optimizing Haploidentical Hematopoietic Stem Cell Transplantation: Enhancing Outcomes in Hematologic Malignancies in Resource-Limited Settings.优化单倍型相合造血干细胞移植：改善资源有限环境下血液系统恶性肿瘤的治疗结局
J Blood Med. 2025 Mar 30;16:151-161. doi: 10.2147/JBM.S511039. eCollection 2025.
4
The Role of Measurable Residual Disease (MRD) in Hematopoietic Stem Cell Transplantation for Hematological Malignancies Focusing on Acute Leukemia.可测量残留疾病（MRD）在血液系统恶性肿瘤（以急性白血病为主）造血干细胞移植中的作用。
Int J Mol Sci. 2019 Oct 28;20(21):5362. doi: 10.3390/ijms20215362.
5
Hematopoietic stem cell transplantation for hematological malignancies in Europe.欧洲血液系统恶性肿瘤的造血干细胞移植
Leukemia. 2003 May;17(5):941-59. doi: 10.1038/sj.leu.2402896.
6
Hematopoietic Stem Cell Transplant for Hematological Malignancies: Experience from a Tertiary Care Center in Northern India and Review of Indian Data.血液系统恶性肿瘤的造血干细胞移植：来自印度北部一家三级医疗中心的经验及印度数据综述
South Asian J Cancer. 2021 Oct 15;11(1):62-67. doi: 10.1055/s-0041-1731599. eCollection 2022 Jan.
7
Profile of Hepatobiliary Dysfunction in Hematopoietic Stem Cell Transplant Recipients - An Indian Perspective.造血干细胞移植受者肝胆功能障碍概况——印度视角
J Clin Exp Hepatol. 2021 Jan-Feb;11(1):14-20. doi: 10.1016/j.jceh.2020.06.006. Epub 2020 Jul 2.
8
Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!成人血液系统恶性肿瘤的供者来源选择：2017 年，为所有患者寻找合适的供者！
Oncologist. 2017 Sep;22(9):1125-1134. doi: 10.1634/theoncologist.2017-0009. Epub 2017 May 25.
9
[Hematopoietic stem cell transplantation for hematological malignancies].[血液系统恶性肿瘤的造血干细胞移植]
Hunan Yi Ke Da Xue Xue Bao. 2002 Jun 28;27(3):242-4.
10
Interferon gamma release assay has potential in the prediction of chronic graft-versus-host disease in recipients of myeloablative allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis.干扰素γ释放试验在接受清髓性异基因造血干细胞移植并采用基于移植后环磷酰胺预防移植物抗宿主病的受者慢性移植物抗宿主病预测方面具有潜力。
Transpl Immunol. 2025 Feb;88:102166. doi: 10.1016/j.trim.2024.102166. Epub 2024 Dec 21.
本文引用的文献
1
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial.维奈克拉联合地西他滨桥接异基因造血干细胞移植治疗老年急性髓系白血病患者（VEN-DEC GITMO）：多中心、单臂、2 期临床试验的最终报告。
Lancet Haematol. 2024 Nov;11(11):e830-e838. doi: 10.1016/S2352-3026(24)00241-2. Epub 2024 Sep 20.
2
ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies.美国血液与骨髓移植学会（ASTCT）关于供者特异性抗人白细胞抗原（HLA）抗体患者检测与治疗的共识建议
Transplant Cell Ther. 2024 Dec;30(12):1139-1154. doi: 10.1016/j.jtct.2024.09.005. Epub 2024 Sep 10.
3
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial.在急性髓系白血病的异基因移植中，白消安-氟达拉滨与白消安-环磷酰胺的比较：GITMO AML-R2 试验的长期分析。
Blood Cancer J. 2024 Aug 21;14(1):141. doi: 10.1038/s41408-024-01116-5.
4
Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation.阿巴西普用于异基因造血细胞移植后急性移植物抗宿主病的预防。
Blood. 2024 Oct 24;144(17):1834-1845. doi: 10.1182/blood.2023023660.
5
Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission.泊那替尼作为一种预防或先发制人策略，用于预防费城染色体阳性急性淋巴细胞白血病患者在完全细胞学缓解状态下接受异基因干细胞移植后出现细胞学复发。
Cancers (Basel). 2024 May 31;16(11):2108. doi: 10.3390/cancers16112108.
6
Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial.维得利珠单抗预防异基因造血干细胞移植后肠道急性移植物抗宿主病：一项随机 3 期试验。
Nat Med. 2024 Aug;30(8):2277-2287. doi: 10.1038/s41591-024-03016-4. Epub 2024 Jun 6.
7
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of .吉特替尼作为伴有. 内部串联重复突变的 AML 移植后维持治疗。
J Clin Oncol. 2024 May 20;42(15):1766-1775. doi: 10.1200/JCO.23.02474. Epub 2024 Mar 12.
8
Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation.移植前blinatumomab 改善接受异基因造血细胞移植的 B 细胞急性淋巴细胞白血病患者的结局。
Transplant Cell Ther. 2024 May;30(5):520.e1-520.e12. doi: 10.1016/j.jtct.2024.03.004. Epub 2024 Mar 8.
9
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group.骨髓纤维化异基因造血干细胞移植的适应证和处理：EBMT/ELN 国际工作组的更新建议。
Lancet Haematol. 2024 Jan;11(1):e62-e74. doi: 10.1016/S2352-3026(23)00305-8. Epub 2023 Dec 4.
10
Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial.异基因造血干细胞移植后索拉非尼维持治疗 FLT3-ITD 急性髓系白血病患者：一项开放标签、多中心、随机、3 期临床试验的长期随访。
Lancet Haematol. 2023 Aug;10(8):e600-e611. doi: 10.1016/S2352-3026(23)00117-5. Epub 2023 Jul 3.
Zotero 插件